Impact of the use of antibiotics on the clinical response to immune checkpoint inhibitors in patients with non-small cell lung cancer

OBJECTIVES: Recent research suggests that the use of antibiotics could reduce the efficacy of checkpoint inhibitors, in addition to other well-known factors. It could be due to gut microbiota modification, which impact over the immune system response. However, the information available so far is con...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbosa, Cristina Martinez-Mugica, Lletí, Ana Cristina Cercós, Sánchez, Rubén Pampín, Román, Cristina Durán, Alonso, Paloma Terroba, González, Beatriz Fernández
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Quimioterapia 2022
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728602/
https://www.ncbi.nlm.nih.gov/pubmed/36164854
http://dx.doi.org/10.37201/req/040.2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728602/
https://www.ncbi.nlm.nih.gov/pubmed/36164854
http://dx.doi.org/10.37201/req/040.2022

Ejemplares similares